TISAGENLECLEUCEL FOR RELAPSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN A PATIENT WITH A CHEK2 MUTATION

被引：0
|
作者：
Ipe, Abraham [1 ]
Angiolillo, Anne [1 ]
Wills, Melissa [1 ]
Wyche, Erica [1 ]
Webb, Jennifer [1 ]
Cheng, Jinjung [1 ]
Jacobsohn, David [1 ]
Bornhorst, Miriam [1 ]
Turner, Joyce [1 ]
Vatsayan, Anant [1 ]
机构：
[1] Childrens Natl Hosp, Washington, DC USA
来源：
PEDIATRIC BLOOD & CANCER | 2022年 / 69卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
541
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Blinatumomab: A ray of hope for relapsed/refractory adult B-cell acute lymphoblastic leukemia
    Kapoor, Akhil
    Rajput, Prakash Singh
    Beniwal, Surender
    Kumar, Harvindra Singh
    CLINICAL CANCER INVESTIGATION JOURNAL, 2014, 3 (06): : 577 - 578
  • [32] Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia
    Hidefumi Hiramatsu
    Souichi Adachi
    Katsutsugu Umeda
    Itaru Kato
    Lamis Eldjerou
    Andrea Chassot Agostinho
    Kazuto Natsume
    Kota Tokushige
    Yoko Watanabe
    Stephan A. Grupp
    International Journal of Hematology, 2020, 111 : 303 - 310
  • [33] Efficacy and safety of tisagenlecleucel in Japanese pediatric and young adult patients with relapsed/refractory B cell acute lymphoblastic leukemia
    Hiramatsu, Hidefumi
    Adachi, Souichi
    Umeda, Katsutsugu
    Kato, Itaru
    Eldjerou, Lamis
    Agostinho, Andrea Chassot
    Natsume, Kazuto
    Tokushige, Kota
    Watanabe, Yoko
    Grupp, Stephan A.
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2020, 111 (02) : 303 - 310
  • [34] GVHD FOLLOWING TISAGENLECLEUCEL FOR RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT
    Moskop, Amy
    Phelan, Rachel
    Atallah, Ehab
    Anderson, Lynnette
    Rao, Sidhar
    Margolis, David
    Talano, Julie
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S229 - S230
  • [35] Real-World Treatment of Pediatric Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia Using Tisagenlecleucel That Is out of Specification for Commercial Release
    Rossoff, Jenna
    Baggott, Christina
    Prabhu, Snehit
    Pacenta, Holly
    Phillips, Christine L.
    Stefanski, Heather
    Talano, Julie-An
    Moskop, Amy
    Margossian, Steven P.
    Verneris, Michael R.
    Myers, Gary Douglas
    Karras, Nicole
    Brown, Patrick A.
    Qayed, Muna
    Hermiston, Michelle
    Satwani, Prakash
    Krupski, Christa
    Keating, Amy
    Wilcox, Rachel
    Rabik, Cara A.
    Fabrizio, Vanessa
    Kunicki, Michael
    Chinnabhandar, Vasant
    Goksenin, A. Yasemin
    Curran, Kevin J.
    Mackall, Crystal L.
    Laetsch, Theodore W.
    Schultz, Liora M.
    BLOOD, 2020, 136
  • [36] Intraocular B-cell Acute Lymphoblastic Leukemia
    Francis, Jasmine H.
    Orlin, Anton
    Stein, Eytan M.
    OPHTHALMOLOGY RETINA, 2018, 2 (08): : 826 - 826
  • [37] Real-World Adverse Events Associated with Tisagenlecleucel in Acute Lymphoblastic Leukemia and Large B-Cell Lymphoma
    Zettler, Marjorie E.
    Feinberg, Bruce
    Balanean, Alexandrina
    Gajra, Ajeet
    BLOOD, 2020, 136
  • [38] Real World Treatment of Pediatric Patients with Down Syndrome and Relapsed/Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (B-All) Treated with Tisagenlecleucel
    Pacenta, H.
    Schultz, L.
    Baggott, C.
    Shah, N.
    Prabhu, S.
    Phillips, C.
    Rossoff, J.
    Stefanski, H.
    Talano, J. -A.
    Moskop, A.
    Margossian, S.
    Verneris, M.
    Myers, G.
    Karras, N.
    Brown, P.
    Qayed, M.
    Hermiston, M.
    Satwani, P.
    Krupski, C.
    Keating, A.
    Wilcox, R.
    Rabik, C.
    Fabrizio, V.
    Rouce, R.
    Chinnabhandar, V.
    Kunicki, M.
    Barsan, V.
    Goksenin, A.
    Curran, K.
    Mackall, C.
    Laetsch, T.
    PEDIATRIC BLOOD & CANCER, 2021, 68 : S87 - S88
  • [39] Direct CNS administration of rituximab and epratuzumab in a pediatric patient with relapsed refractory CNS B-cell acute lymphoblastic leukemia
    McClane, Jenna
    Chawla, Anjulika
    Welch, Jennifer J. G.
    PEDIATRIC BLOOD & CANCER, 2022, 69 (06)
  • [40] Bortezomib and low dose venetoclax therapy for relapsed/refractory B-cell acute lymphoblastic leukemia with IDH1 mutation
    Borah, Pronamee
    Maitri, Ayoniza
    Naithani, Rahul
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2024, 46 : S435 - S437
12345